2015-2023 World Rosuvastatin Calcium Market Research Report by Product Type, End-User / Application and Regions / Countries - Business Industry Reports

2015-2023 World Rosuvastatin Calcium Market Research Report by Product Type, End-User / Application and Regions / Countries


  • May 2018
  • |
  • 126
  • |
  • Life Sciences
  • |
  • HeyReport

Summary
Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart attack and stroke.Rosuvastatin calcium is a hygroscopic powder suitable for the manufacture of tablets and capsules. The appropriate excipients need to be added. The particle size of the product is designed in such a way that optimal dissolution can be obtained (depending on formulation).Rosuvastatin Calcium is a member of the drug class of statins, used in combination with exercise, diet, and weight-loss to treat high cholesterol and related conditions, and to prevent cardiovascular disease. It works by slowing the production of cholesterol in the body to decrease the amount of cholesterol that may build up on the walls of the arteries and block blood flow to the heart, brain, and other parts of the body. Rosuvastatin Calcium was developed by Shionogi and has been formulated into finished oral dosage form and marketedby AstraZeneca as Crestor, Abbott Laboratories as R2.
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
Market Segment as follows:
By Region / Countries
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc)
South America (Brazil, Argentina etc)
Middle East & Africa (Saudi Arabia, South Africa etc)
By Type
Purity 98.0%
Purity 99.0%
Others
By End-User / Application
Tablet (including dispersible tablet and general tablet)
Capsule
Others
By Company
AstraZeneca
Teva Pharmaceutical Industries
MSN Laboratories
Cadila Pharmaceuticals
LGM Pharma
Bal Pharma
Changzhou Pharmaceutical Factory
Jingxin Pharm
Zhejiang Hisun Pharmaceutical
HEC Pharm
Lunan Pharmaceutical
Nanjing Frochem Tech
Lianyungang Runzhong Pharmaceutical
Shandong Bechem Chemicals
CTX Life Sciences
Table of Contents
1 Market Definition
1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application
2 Global Market by Vendors
2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors
3 Global Market by Type
3.1 Market Share
3.2 Introduction of End-Use by Different Products
4 Global Market by End-Use / Application
4.1 Market Share
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs
5 Global Market by Regions
5.1 Market Share
5.2 Regional Market Growth
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Middle East & Africa
6 North America Market
6.1 by Type
6.2 by End-Use / Application
6.3 by Regions
7 Europe Market
7.1 by Type
7.2 by End-Use / Application
7.3 by Regions
8 Asia-Pacific Market
8.1 by Type
8.2 by End-Use / Application
8.3 by Regions
9 South America Market
9.1 by Type
9.2 by End-Use / Application
9.3 by Regions
10 Middle East & Africa Market
10.1 by Type
10.2 by End-Use / Application
10.3 by Regions
11 Market Forecast
11.1 Global Market Forecast (2018-2023)
11.2 Market Forecast by Regions (2018-2023)
11.3 Market Forecast by Type (2018-2023)
11.4 Market Forecast by End-Use / Application (2018-2023)
12 Key Manufacturers
12.1 AstraZeneca
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 Teva Pharmaceutical Industries
12.2.1 Company Overview
12.2.2 Product and End-User / Application
12.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.3 MSN Laboratories
12.3.1 Company Overview
12.3.2 Product and End-User / Application
12.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.4 Cadila Pharmaceuticals
12.4.1 Company Overview
12.4.2 Product and End-User / Application
12.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.5 LGM Pharma
12.5.1 Company Overview
12.5.2 Product and End-User / Application
12.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.6 Bal Pharma
12.12.1 Company Overview
12.12.2 Product and End-User / Application
12.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.7 Changzhou Pharmaceutical Factory
12.7.1 Company Overview
12.7.2 Product and End-User / Application
12.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.8 Jingxin Pharm
12.8.1 Company Overview
12.8.2 Product and End-User / Application
12.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.9 Zhejiang Hisun Pharmaceutical
12.9.1 Company Overview
12.9.2 Product and End-User / Application
12.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.10 HEC Pharm
12.10.1 Company Overview
12.10.2 Product and End-User / Application
12.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.11 Lunan Pharmaceutical
12.12 Nanjing Frochem Tech
12.13 Lianyungang Runzhong Pharmaceutical
12.14 Shandong Bechem Chemicals
12.15 CTX Life Sciences
9 Research Conclusion
Sample Request is not available
Summary is not available